These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14645350)

  • 21. Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma.
    Leek RD; Landers R; Fox SB; Ng F; Harris AL; Lewis CE
    Br J Cancer; 1998 Jun; 77(12):2246-51. PubMed ID: 9649140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymidine phosphorylase and breast carcinoma.
    Yang Q; Yoshimura G; Mori I; Sakurai T; Kakudo K
    Anticancer Res; 2002; 22(4):2355-60. PubMed ID: 12174926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymidine phosphorylase (platelet-derived endothelial cell growth factor), microvessel density and clinical outcome in hepatocellular carcinoma.
    Yamamoto A; Dhar DK; El-Assal ON; Igarashi M; Tabara H; Nagasue N
    J Hepatol; 1998 Aug; 29(2):290-9. PubMed ID: 9722211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas.
    Vakkala M; Kahlos K; Lakari E; Pääkkö P; Kinnula V; Soini Y
    Clin Cancer Res; 2000 Jun; 6(6):2408-16. PubMed ID: 10873093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of monocyte chemotactic protein-1 and thymidine phosphorylase in angiogenesis of human cardiac myxoma.
    Zhang T; Koide N; Wada Y; Tsukioka K; Takayama K; Kono T; Kitahara H; Amano J
    Circ J; 2003 Jan; 67(1):54-60. PubMed ID: 12520153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microvessel density, proliferating activity, p53 and bcl-2 expression in in situ ductal carcinoma of the breast.
    Zolota V; Gerokosta A; Melachrinou M; Kominea A; Aletra C; Scopa CD
    Anticancer Res; 1999; 19(4B):3269-74. PubMed ID: 10652623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiogenesis in gastric cancer: importance of the thymidine phosphorylase expression of cancer cells as an angiogenic factor.
    Han HS; Hwang TS
    Oncol Rep; 2007 Jan; 17(1):61-5. PubMed ID: 17143479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microvessel quantitation in intraductal and early invasive breast carcinomas.
    Santinelli A; Baccarini M; Colanzi P; Fabris G
    Anal Quant Cytol Histol; 2000 Aug; 22(4):277-84. PubMed ID: 10965402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancers.
    Gunningham SP; Currie MJ; Morrin HR; Tan EY; Turley H; Dachs GU; Watson AI; Frampton C; Robinson BA; Fox SB
    J Pathol; 2007 Jul; 212(3):335-44. PubMed ID: 17487938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer.
    Toi M; Hoshina S; Taniguchi T; Yamamoto Y; Ishitsuka H; Tominaga T
    Int J Cancer; 1995 Apr; 64(2):79-82. PubMed ID: 7542228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of ELISA level and immunohistochemical status for thymidine phosphorylase (TP) in invasive breast carcinoma.
    Kurosumi M; Sugamata N; Tabei T; Inoue K; Matsumoto H; Suemasu K; Higashi Y
    Anticancer Res; 2002; 22(1A):331-8. PubMed ID: 12017313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of thymidine phosphorylase in cancer].
    Jiang LN; Yu SY; Xiong HH; Zhang MX
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):297-9. PubMed ID: 15312368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of visual and automated assessment of microvessel density and their impact on outcome in primary operable invasive ductal breast cancer.
    Mohammed ZM; Orange C; McMillan DC; Mallon E; Doughty JC; Edwards J; Going JJ
    Hum Pathol; 2013 Aug; 44(8):1688-95. PubMed ID: 23574778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma.
    Vartanian RK; Weidner N
    Am J Pathol; 1994 Jun; 144(6):1188-94. PubMed ID: 7515558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor.
    Nielsen BS; Rank F; Illemann M; Lund LR; Danø K
    Int J Cancer; 2007 May; 120(10):2086-95. PubMed ID: 17290405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymidine phosphorylase expression in tumor stroma of uterine cervical carcinomas: histological features and microvessel density.
    Tang W; Wang X; Utsunomiya H; Nakamuta Y; Yang Q; Zhang Q; Zhou G; Tsubota Y; Mabuchi Y; Li L; Kakudo K
    Cancer Lett; 2000 Feb; 148(2):153-9. PubMed ID: 10695991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting the biologic behavior of ductal carcinoma in situ: an analysis of molecular markers.
    Hieken TJ; Farolan M; D'Alessandro S; Velasco JM
    Surgery; 2001 Oct; 130(4):593-600; discussion 600-1. PubMed ID: 11602889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of thymidine phosphorylase in epithelial ovarian cancer: correlation with angiogenesis, apoptosis, and ultrasound-derived peak systolic velocity.
    Hata K; Fujiwaki R; Maede Y; Nakayama K; Fukumoto M; Miyazaki K
    Gynecol Oncol; 2000 Apr; 77(1):26-34. PubMed ID: 10739687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer.
    Costa C; Soares R; Reis-Filho JS; Leitão D; Amendoeira I; Schmitt FC
    J Clin Pathol; 2002 Jun; 55(6):429-34. PubMed ID: 12037025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of thymidine phosphorylase (TP) mRNA expression in angiogenesis of prostate cancer.
    Kikuno N; Yoshino T; Urakami S; Shigeno K; Kishi H; Hata K; Shiina H; Igawa M
    Anticancer Res; 2003; 23(2B):1305-12. PubMed ID: 12820387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.